(19)
(11) EP 1 720 485 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2016 Bulletin 2016/41

(45) Mention of the grant of the patent:
03.08.2016 Bulletin 2016/31

(21) Application number: 05712671.6

(22) Date of filing: 03.02.2005
(51) International Patent Classification (IPC): 
A61L 27/16(2006.01)
B29C 43/00(2006.01)
 A61L 27/50(2006.01)
C08J 3/28(2006.01)
(86) International application number:
PCT/US2005/003305
(87) International publication number:
WO 2005/074619 (18.08.2005 Gazette 2005/33)

(54)

HIGHLY CRYSTALLINE CROSS-LINKED OXIDATION-RESISTANT POLYETHYLENE

HOCHKRISTALLINES VERNETZTES OXIDATIONSRESISTENTES POLYETHYLEN

POLYETHYLENE RETICULE HAUTEMENT CRISTALLIN RESISTANT A L'OXYDATION

(84) Designated Contracting States:
CH DE ES FR GB IT LI

(30) Priority: 03.02.2004 US 541073 P

(43) Date of publication of application:
15.11.2006 Bulletin 2006/46

(60) Divisional application:
16182409.9

(73) Proprietor: The General Hospital Corporation
Boston, MA 02114 (US)

(72) Inventors:
  • MURATOGLU, Orhun, K.
    Cambridge, MA 02138 (US)
  • ORAL, Ebru
    Somerville, MA 02143 (US)

(74) Representative: Davies, Jonathan Mark 
Reddie & Grose LLP 16 Theobalds Road
London WC1X 8PL
London WC1X 8PL (GB)


(56) References cited: : 
US-A- 5 827 904
US-B1- 6 316 158
US-B2- 6 620 198
 US-A1- 2002 107 300
US-B2- 6 517 857
   
  • MARAATOGLU ET AL: 'Unified wear model got highly crosslinked ultra.high molecular weight polythylene (UHMWPE)' BIOMATERIALS vol. 20, 1999, pages 1463 - 1470, XP008117352
  • PARTH ET AL.: 'Studies on the effect of electron beam radiation on the molecular structure of ultra-high molecualr weight polytheylene under the influence of a-tocopherol with respect to its application in medical implants' JOURNAL OF MATERIAL SCIENCE vol. 13, 2002, pages 917 - 921, XP008053056
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).